Safety and immunogenicity of a recombinant hepatitis B vaccine-Reference-Cited by-同舟云学术

Safety and immunogenicity of a recombinant hepatitis B vaccine

Published:1985-09 Issue:1 Volume:17 Page:57-62
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J. Med. Virol.

Author:

Dandolos E.,Roumeliotou-Karayannis A.,Richardson S. C.,Papaevangelou G.

Publisher

Wiley

Subject

Infectious Diseases,Virology

Reference14 articles.

1. PREVENTION OF PERINATALLY TRANSMITTED HEPATITIS B VIRUS INFECTIONS WITH HEPATITIS B IMMUNE GLOBULIN AND HEPATITIS B VACCINE

2. AFFINITY OF ANTIBODY RESPONSES IN MAN TO HEPATITIS B VACCINE DETERMINED WITH SYNTHETIC PEPTIDES

3. IMMUNOGENICITY OF RECOMBINANT YEAST HEPATITIS B VACCINE

4. , , (1982): Response to hepatitis B vaccine in a young adult population. In , (eds): “Viral Hepatitis. 1981 International Symposium.” Philadelphia: Franklin Institute Press, pp 451–466.

5. HEPATITIS B VACCINATION: HOW LONG DOES PROTECTION LAST?

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanovaccines and the History of Vaccinology;Nanovaccines;2019

2. Higher disappearance rate of anti-HBs in Taiwanese freshers neonatally vaccinated with recombinant yeast hepatitis B vaccine;Liver International;2017-04-27

3. Vaccine technologies: From whole organisms to rationally designed protein assemblies;Biochemical Pharmacology;2016-11

4. On DNA vaccines and prolonged expression of immunogens;European Journal of Immunology;2006-04

5. Phase I clinical trial safety of DNA- and modified virus Ankara-vectored human immunodeficiency virus type 1 (HIV-1) vaccines administered alone and in a prime-boost regime to healthy HIV-1-uninfected volunteers;Vaccine;2006-01-23